Bi-directional regulation between tyrosine kinase Etk/BMX and tumor suppressor p53 in response to DNA damage

被引:32
作者
Jiang, TY
Guo, ZY
Dai, BJ
Kang, MY
Ann, DK
Kung, HJ
Qiu, Y
机构
[1] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA
[2] Univ So Calif, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA
[3] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA
关键词
D O I
10.1074/jbc.M409108200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Etk/Bmx, a member of the Tec family of nonreceptor tyrosine kinases, has been implicated in the regulation of various cellular processes including proliferation, differentiation, motility, and apoptosis. Here, we report the identification of Tec family kinases as the potential interacting proteins of the tumor suppressor p53 by an Src homology 3 domain array screening. Etk is physically associated with p53 through its Src homology 3 domain and the proline-rich domain of p53. Induction of p53 expression by DNA damage inhibits Etk activity in several cell types. Down-regulation of Etk expression by a specific small interfering RNA sensitizes prostate cancer cells to doxorubicin-induced apoptosis, suggesting that inhibition of Etk activity is required for apoptosis in response to DNA damage. We also show that Etk primarily interacts with p53 in the cytoplasm and that such interaction leads to bidirectional inhibition of the activities of both proteins. Overexpression of Etk in prostate cancer cells results in inhibition of p53 transcriptional activity and its interaction with the mitochondrial protein BAK and confers the resistance to doxorubicin. Therefore, we propose that the stoichiometry between p53 and the Tec family kinases in a given cell type may determine its sensitivity to chemotherapeutic drugs.
引用
收藏
页码:50181 / 50189
页数:9
相关论文
共 43 条
  • [1] Agami R, 1999, NATURE, V399, P809
  • [2] Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells
    Bagheri-Yarmand, R
    Mandal, M
    Taludker, AH
    Wang, RA
    Vadlamudi, RK
    Kung, HJ
    Kumar, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) : 29403 - 29409
  • [3] The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells
    Baptiste, N
    Friedlander, P
    Chen, XB
    Prives, C
    [J]. ONCOGENE, 2002, 21 (01) : 9 - 21
  • [4] Retroviral delivery of small interfering RNA into primary cells
    Barton, GM
    Medzhitov, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (23) : 14943 - 14945
  • [5] Coordinating Etk/Bmx activation and VEGF upregulation to promote cell survival and proliferation
    Chau, CH
    Chen, KY
    Deng, HT
    Kim, KJ
    Hosoya, K
    Terasaki, T
    Shih, HM
    Ann, DK
    [J]. ONCOGENE, 2002, 21 (57) : 8817 - 8829
  • [6] CHEADLE C, 1994, J BIOL CHEM, V269, P24034
  • [7] Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain
    Chen, RY
    Kim, O
    Li, M
    Xiong, XS
    Guan, JL
    Kung, HJ
    Chen, HG
    Shimizu, Y
    Qiu, Y
    [J]. NATURE CELL BIOLOGY, 2001, 3 (05) : 439 - 444
  • [8] Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis
    Chipuk, JE
    Kuwana, T
    Bouchier-Hayes, L
    Droin, NM
    Newmeyer, D
    Schuler, M
    Green, DR
    [J]. SCIENCE, 2004, 303 (5660) : 1010 - 1014
  • [9] Correction of the X-linked immunodeficiency phenotype by transgenic expression of human Bruton tyrosine kinase under the control of the class II major histocompatibility complex Ea locus control region
    Drabek, D
    Raguz, S
    DeWit, TPM
    Dingjan, GM
    Savelkoul, HFJ
    Grosveld, F
    Hendriks, RW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (02) : 610 - 615
  • [10] Gong JG, 1999, NATURE, V399, P806